BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34238665)

  • 1. Long non-coding RNA TPTEP1 exerts inhibitory effects on hepatocellular carcinoma by impairing microRNA-454-3p-mediated DLG5 downregulation.
    Dong Y; Wang Q; Sun J; Liu H; Wang H
    Dig Liver Dis; 2022 Feb; 54(2):268-279. PubMed ID: 34238665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H; Liu J; Zou R; Cheng P; Su Y
    J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.
    Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X
    Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 6. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
    J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
    Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y
    Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
    Yin J; Liu Q; Chen C; Liu W
    J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma.
    Zhu X; Yu H; Li B; Quan J; Zeng Z; Li G; Liu J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 30541900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis.
    Zhou Y; Li K; Zou X; Hua Z; Wang H; Bian W; Wang H; Chen F; Dai T
    Bioengineered; 2021 Dec; 12(2):10862-10877. PubMed ID: 34666613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
    Hu L; Ye H; Huang G; Luo F; Liu Y; Liu Y; Yang X; Shen J; Liu Q; Zhang J
    Tumour Biol; 2016 Feb; 37(2):2691-702. PubMed ID: 26404135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling.
    Tang T; Wang LX; Yang ML; Zhang RM
    Mol Med Rep; 2020 Dec; 22(6):4857-4867. PubMed ID: 33173989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
    J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.